COMP <GO>
MMED vs STVN // FORWARD P/E MULTIPLE
MiniMed Group Inc. (NASDAQ) VS. Stevanato Group S.p.A. (NYSE) • 15-METRIC TALLY: MMED 0
— STVN 2
■ METRIC PARITY
LAST: $18.90 (+3.39%) • MKT CAP: $5.14B
forward-pe
24.0x
LAST: $19.74 (+1.86%) • MKT CAP: $5.29B
forward-pe
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MMED VS. STVN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MMED | STVN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 54.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -3.90% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -7.75% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -6.10% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -10.70% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 14.30% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.82 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.5 | 45.5 | -1.00 | STVN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 24.0x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.14B | $5.29B | -$147.7M | STVN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MMED REV | STVN REV | MMED GROSS % | STVN GROSS % | MMED FCF | STVN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.10B | — | 54.2% | — | -$420.0M | — |
| FY 2024 | $2.71B | — | 56.3% | — | -$53.0M | — |
| FY 2023 | $2.47B | — | — | — | -$70.1M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MMED // BETA 1.05
STVN // BETA —